To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion Wk chg 11/7 cls
Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) H.C. Wainwright Swayampakula Ramakanth Downgrade Neutral (from buy) -47% C$0.66
Ramakanth downgraded after FDA issued a complete response letter for an NDA for Macrilen macimorelin acetate (AEZS-130) to diagnose adult growth hormone deficiency (GHD). FDA requested the company conduct an additional confirmatory trial plus a QT

Read the full 832 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE